Charles Theuer, M.D., Ph.D.

President & CEO, TRACON Pharmaceuticals

Charles Theuer, M.D., Ph.D.

President & CEO, TRACON Pharmaceuticals

Biography

Dr. Theuer has served as President, Chief Executive Officer and a member of TRACON Pharmaceutical’s board of directors since July 2006. Prior to joining TRACON Pharmaceuticals, Dr. Theuer was the Chief Medical Officer and Vice President of Clinical Development at TargeGen, Inc., a biotechnology company, where he led the development of small molecule kinase inhibitors in oncology, ophthalmology and cardiovascular disease. In addition, Dr. Theuer was Director of Clinical Oncology at Pfizer, Inc., where he led the clinical development of Sutent® in kidney cancer, and has held senior positions at IDEC Pharmaceuticals Corp. and at the National Cancer Institute. Dr. Theuer has also held academic positions at the University of California, Irvine, where he was Assistant Professor in the Division of Surgical Oncology and Department of Medicine.

Dr. Theuer received a Bachelor of Science from the Massachusetts Institute of Technology, a Medical Degree from the University of California, San Francisco, and a Ph.D. from the University of California, Irvine. He completed a general surgery residency program at Harbor-UCLA Medical Center and was board certified in general surgery in 1997.  Dr. Theuer’s previous research involved immunotoxin and cancer vaccine development, translational work in cancer patients, and gastrointestinal cancer epidemiology.

All session by Charles Theuer, M.D., Ph.D.

Session 2: Treatment of HHT

10:20 am - 12:20 pm
Soderini Ballroom II, III